Published in

Elsevier, European Urology Open Science, (46), p. 39-42, 2022

DOI: 10.1016/j.euros.2022.10.002

Elsevier, European Urology, (83), p. S676-S677, 2023

DOI: 10.1016/s0302-2838(23)00520-1

Links

Tools

Export citation

Search in Google Scholar

Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO